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Introduction

The epidemiological context

Mathematical models that capture COVID-19 dynamics
have supported public health responses and policy
development since the beginning of the pandemic,1,2
yet there is limited discourse to describe features of an
optimal modelling platform to support policy decisions
or how modellers and policy makers have engaged with
each other. Here, we outline how we used a modelling
software platform to support public health decision
making for the COVID-19 response in the Western
Pacific Region (WPR) countries of the Philippines,
Malaysia and Viet Nam. This perspective describes an
approach to support evidence-based public health decisions and policy, which may help inform other
responses to similar outbreak events. The platform we
describe formed the basis for one of the inaugural
World Health Organization (WHO) Western Pacific
(WPRO) Innovation Challenge awards, and was backed
by collaboration between epidemiological modellers,
those providing public health advice, and policy makers.

The WPR includes demographically, socioeconomically
and culturally diverse countries, which has resulted in
major differences in the timing, size, and duration of
COVID-19 epidemic waves.3 Variations in public health
responses and differential access to vaccine supply have
further contributed to these differences.4 Figure 1 illustrates the different trajectories of the lower-middle income
countries (LMIC) the Philippines and Viet Nam, and the
upper-middle income country Malaysia over the course of
the pandemic.5−7 This demonstrates that early in the pandemic, the Philippines, Malaysia and Viet Nam, were able
to maintain a low COVID-19 burden compared to countries in highly affected regions, such as Europe and the
Americas.4 This was achieved through various combinations of international border restrictions with quarantine
for incoming travellers, lockdowns (“community
quarantine” or “movement control” orders), personal protective behaviours (e.g., mask wearing and social distancing), and strong testing and isolation strategies.8 However,
like many countries around the world, they have experienced a high burden of transmission and infection following the emergence of the Delta and Omicron variants
(Figure 1, Table 1).3,9
These differences in epidemiology highlight the
importance of delivering context-dependent modelling
to support local public health decision-making. To capture transmission and disease dynamics accurately,
modelling must be relevant to the current local context
with respect to surveillance data, population
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Figure 1. Epidemic curves over the course of the pandemic for a. the Philippines, b. Malaysia and c. Viet Nam. Curves show the 7-day
moving average of new cases per million population as of 4 July 2022. Daily reported case data for each country sourced from the
COVID-19 data repositry made available by the Centre for Systems Science and Engineering at John Hopkins University.5 Note the
difference in y-axis scales. Grey dashed lines indicate vaccination coverage milestones. d = Date of ﬁrst day of fortnightly reporting
for ﬁrst Delta case in each country by covariants.org. o = Date of ﬁrst day of fortnightly reporting for ﬁrst Omicron case in each country by Covariants.org. Covariants.org utilises genomic sequences shared via GISAID, the global data science initiative.6,7
Start = commencement of vaccine rollout in the general population (estimated as the ﬁrst date that population coverage was
reported), 50% = 50% 2-dose coverage and 80% = 80% 2-dose coverage. 80% coverage not shown for Philippines, as 2-dose coverage less than 80% as of 4 July 2022.All estimates use whole population estimates as the denominator to facilitate comparison
between countries and avoid issues with policy changes in age-speciﬁc vaccine eligibility over time. Vaccine coverage data sourced
from Data on COVID-19 vaccinations, made available by Our World in Data.10

demographics, underlying population immunity, and
the implementation and adherence to public health and
social measures over time (PHSM, such as facemasks
and mobility restrictions).

A software platform to support infectious
disease policy decisions
The open-access modelling software platform
“AuTuMN” served as a key tool to capture COVID-19
dynamics in the Philippines, Malaysia, and Viet Nam.11
The aim of our platform is the integration of epidemiological concepts and dynamic disease transmission
models with software engineering and data science
principles. In Figure 2, we show an example of the code
needed to construct a simple susceptible-infectedexposed (SIR) model using features of the platform.
The platform's central infrastructure is designed around

2

pluggable modules tailored to specific epidemiological
phenomena and is applicable to a range of contexts. In
addition to features relevant to infectious diseases, the
infrastructure allows for deployment to cloud computing environments and integration with commonly used
data science tools, such as Jupyter notebooks. This
includes functionality for retrieving and interacting
with model outputs locally, such that the platform aims
to optimise both computational performance and
end-to-end modelling workflow. The platform was
designed and developed with open-source software
best practices in mind.12 This approach has many
benefits, but the key principles are transparency,
reproducibility, error avoidance, and collaboration
through online version control utilising the widely
used source code management platform Github
(https://github.com/monash-emu/AuTuMN). This
practice is in line with a growing movement to
ensure that the code used to produce COVID-19
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Country application
Philippines

Malaysia

Viet Nam

Key country stakeholders and liaison organisations
National agencies

The Malaysian Health Tech-

The Ministry of Information

Group on Data Analytics

nology Assessment Sec-

and Communications

of the Inter-Agency Task

tion, Ministry of Health

The Sub-Technical Working

Force for Emerging Infectious Diseases (IATF STWG
DA)
Epidemiology Bureau, The
Department of Health
University-afﬁliated research
groups

Ateneo de Manila University

(MaHTAS)
Institute for Clinical
Research (ICR), NIH
Institute for Public Health
(IKU), NIH
Monash University

Monash University
The University of Sydney

Monash University
James Cook University

International agencies

WHO Country Ofﬁce

WHO Country Ofﬁce

WHO Regional Ofﬁce for the

WHO Regional Ofﬁce for the

Western Paciﬁc
Independent not-for-proﬁt

The Australian Department of
Foreign Affairs and Trade

Western Paciﬁc

FASSSTERa

The Woolcock Institute of

research institutes/groups

Medical Research, Viet Nam

COVID-19 burdenb
Cumulative cases (per million)

32,573

136,291

110,286

Cumulative deaths (per million)

532

1066

442

2-dose coverage

62.8%

81.4%

82.3%

Booster coverage

13.4%

48.6%

63.0%

 What is the projected size
and peak in COVID-19
cases, hospitalisations,
ICU beds occupied, and
deaths from the Delta variant in Calabarzon, July to
September 2021?
 What is the projected size
and peak in COVID-19
cases, hospitalisations,
ICU beds occupied, and
deaths from the Omicron
variant in the National
Capital Region, Philippines, January to February 2022?

 What is the projected size
and peak in COVID-19
cases, hospitalisations,
ICU beds occupied, and
deaths at a national level
from the Delta variant,
August to October 2021?
 What are the projected
effects on COVID-19 case
numbers and health care
utilisation at a national
level following the introduction of new variants of
concern with particular
characteristics into Malaysia following the Omicron
wave in February to
March 2022?

 What is the projected size
and peak of COVID-19
cases, hospitalisations, ICU
bed occupancy, and fatalities from the Delta variant
in Ho Chi Minh City, July to
December 2021?
 What is the projected size
and peak of COVID-19
cases, hospitalisations, ICU
bed occupancy, and fatalities from the Omicron variant in Hanoi, February to
April 2022?

 How can compliance to
minimum public health
standards (MPHS) help to
reduce transmission?
 What are the projected
effects of public health
interventions on the Delta
wave trajectory? What
local community quarantine policy will optimally
mitigate infection spread?
 What are the projected
effects of school openings
and easing of mobility
restrictions on the Omicron epidemic?

 Vaccination risk-benefit
analysis: Comparison of
the projected number of
hospitalisations and
deaths prevented due to
immunisation
 What are the projected
effects of school reopenings and easing of mobility restrictions on the
Delta wave epidemic?

 What are the projected
effects of different combinations of school and border
reopenings, and easing of
mobility restrictions on the
Delta and Omicron epidemics?
 Vaccination
cost-benefit
analysis: what is the optimal
booster interval for the
spring 2021 vaccination
campaign?
 What are optimal vaccination recommendations for
people who have completed
the two-dose scheme?

Vaccinationc

Example policy questions
Disease burden and healthcare
capacity

Reducing COVID-19 transmission

Output format

Table 1 (Continued)
www.thelancet.com Vol 00 Month , 2022
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Country application
Philippines

Malaysia

Viet Nam

Model projections provided

Policy briefs and modelling

Public media releases and pol-

to in-country modellers

projection with different

icy briefs to the Ofﬁce of

for incorporation in pre-

scenarios to Ministry of

Government, the Ministry of

sentations of the sub-

Health and the WHO

Health, and the COVID-19

technical working group

Country Ofﬁce

Policy Advisory and Eco-

on Data Analytics (sTWG-

nomic Recovery Group for

DA) to IATF principals

Ho Chi Minh City

Publications
Understanding COVID-19

Sustaining effective COVID-

Draft manuscript only.

dynamics and the effect

19 control in Malaysia

of interventions in the

through large-scale vacci-

Philippines: A mathemati-

nation. Jayasundara et al.

cal modelling study. Cald-

(2021)

well et al. (2021)

Table 1: Summary of modelling initiatives by country.
a

See link: DOH: FASSSTER COVID-19 v4.0 (ehealth.ph) for explanation of FASSSTER.

b

Cumulative cases and deaths as of 4th July 2022. Daily reported case and death data for each country sourced from the COVID-19 data repositry made
available by the Centre for Systems Science and Engineering at John Hopkins University.6
c
2-dose and booster dose coverage as of July 7 2022. Vaccine coverage data sourced from Data on COVID-19 vaccinations, made available by Our World in
Data.10

models and projections is shared openly.13,14 Results
and analysis of specific modelling activities were rapidly communicated through online, interactive dashboards, which policy makers could use to query and
investigate scenarios directly.

Inﬂuencing policy
Overview
The engagement we describe here was instigated to provide near real-time, mechanistic models that simulated

transmission dynamics for viral spread in the Philippines,
Malaysia, and Viet Nam to assist in answering policy-relevant questions for COVID-19 control. Table 1 outlines the
modelling initiative in each country, highlighting the specific collaborating groups, key policy questions modelled,
and how the results were communicated. An overview of
the general workflow is presented in Figure 3 and an example application of the platform to a policy question is presented in Figure 4. In this example, we highlighted how
various booster vaccination strategies could affect the size
of a future epidemic wave due to waning of infectioninduced immunity.

Figure 2. Illustration of code and simple visualisation of construction of a basic Susceptible-Infected-Exposed model using the Summer package, which provides a domain-speciﬁc syntax for infectious disease modelling. Summer underpins model construction
using the AuTuMN platform (Summer documentation (summerepi.com)). Although actual models are typically more complex, the
underlying principle with which we construct compartment models is demonstrated.
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Figure 3. Description of workﬂow for modelling collaboration indicating; key collaborators, sharing of data and information and feedback.
IATF STWG DA = The Sub-Technical Working Group on Data Analytics of the Inter-Agency Task Force for Emerging Infectious Diseases,
DOH = Department of Health, MaHTAS = The Malaysian Health Technology Assessment Section, Ministry of Health, ICR-(NIH) = Institute for
Clinical Research, National Institute of Health, IKU-(NIH) = Institute for Public Health, National Institute of Health.

Building collaborative teams
WHO WPR regional and country offices, along with
the Woolcock Institute of Medical Research, played
the important role of facilitating collaboration among

the modelling team and in-country collaborators.
This collaborative network included national departments/ministries of health, independent not-forprofit research institutes, government-supported

Figure 4. Example of modelling projections to support policy decisions. Figure shows projected hospital occupancy in the Philippines
National Capital Region under various booster vaccination scenarios. We consider monthly booster vaccination rates of 200,000 (black
lines), 500,000 (blue lines) and 1,000,000 (red lines). Scenarios assuming uniform booster allocation across all age groups are shown with
solid lines. Scenarios where older individuals are prioritised for booster vaccination are shown with dashed lines.

www.thelancet.com Vol 00 Month , 2022
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research institutes, and university-affiliated research
groups, that included some local in-country modelling and surveillance expertise (Table 1).
Trust developed between in-country staff (Figure 3) and
the modelling team, supporting an open forum for the discussion and critique of important knowledge for the development and interpretation of dynamic transmission
models. Country teams involved in the local COVID-19
response contributed vital situational awareness of current
epidemiology and the policy and public health decisions
under consideration. When issues arose, appropriate
points of contact were established, allowing for quick trouble-shooting. For instance in the Philippines, early in the
pandemic, the modelling team noticed unusual patterns of
reported COVID-19 mortality, and local public health surveillance expertise was able to identify the patterns being
due difficulties in classifying COVID-19 as a cause of death
and other reasons delaying reporting. Similarly, when incountry teams noticed modeling patterns that did not
reflect local intuition, the reasons for any apparent discrepancies could be identified, and revision to the modelling
approach considered. Once all partners were satisfied with
the model outputs, in-country teams could then use the codeveloped modelling results in the policy and decisionmaking process. This allowed teams working in COVID19 surveillance and response to integrate modelling within
the broader disease surveillance context.

Acceptance and skepticism
Building trust in modelling amongst public health and policy decision-makers working on pandemic response takes
time and can be met with a range of responses. Models
that capture the heterogeneities of the COVID-19 epidemic
and are able to address the specific policy questions (e.g.,
age-specific vaccine allocation) often require substantial
complexity. At the same time, stakeholders in national pandemic responses may have limited experience in the use or
interpretation of modelling. To counter these limitations,
we sought to provide regular explanations of the model
components and associated reasons for the models’ findings to different stakeholder groups and compare the findings with results from complementary models where
possible. The goal was to equip public health officials and
decision makers with the ability to critically assess the
modelling results and understand the inherent strengths
and limitations in what should be inferred.

Obstacles for costly interventions
Globally, policy makers were forced to make decisions about how to manage COVID-19 given incomplete and often conflicting information, considering
the pros and cons of measures of PHSMs. The aim
of our work was to provide policy makers with regular updates on the most relevant and realistic scientific evidence given local context and concerns. We

6

showed the expected impact of different decisions on
public health (e.g., projected cases, hospitalisations)
to support decision making, but generally did not
take our own stance or negotiate for specific policy
decisions, as our teams did not include experts in
other sectors (e.g., economists, educators, industry)
relevant to final policy decisions.

Measuring impact
Impacts of the modelling we describe may include: (i)
strengthening international collaboration and capacity
among infectious disease and pandemic stakeholders in
the WPR; (ii) contributing to scientific knowledge about
COVID-19 dynamics in LMIC and epidemiological modelling; and (iii) exposure of our software platform to a diverse
range of epidemiological settings and questions.
Partners involved in this work have gained new
knowledge, skills, and colleagues as a result of this
process. From a policy standpoint, we recognize that
modelling is only useful to policy decisions when it
is both correct and can inform actionable decisions.
Public health interventions are complex, and require
decision makers to synthesize multiple lines of evidence, of which modelling is just one component.
Some examples of where the modelling presented
here contributed to public health action include:
accurately predicting the timing and magnitude of
epidemic peaks to help inform health system capacity planning, identifying epidemic resurgence was
likely due to the emergence of a new variant of concern in the Philippines and demonstrating how differences vaccination coverage and delivery rate in
Malaysia may affect health system capacity requirements. A reflection of this was the acknowledgement
of modelling outputs in public health media releases
in Viet Nam and the Philippines.15,16
From a scientific standpoint, the collaboration has so
far led to the production of two peer-reviewed papers in the
country contexts of the Philippines and Malaysia,17,18
involving multiple members from across the range of partners and sectors involved. This highlights the strength of
the collaboration and the trust that was built between modellers and in-country stakeholders. The publications were
important in bringing the modelling into the public
domain to support transparency and public engagement.17
Finally, this process has led to investment in, refinement,
and testing of the AuTuMN platform, expanding its applicability to more epidemiological contexts and questions

Lessons learnt
Cross-sectoral collaboration enhances model
development
We found that cross-sectoral collaboration and model
co-development with local experts in each country was

www.thelancet.com Vol 00 Month , 2022
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crucial to the modelling-policy cycle, confirming previous
findings.19,20 This supported access to and understanding
of up-to-date and relevant information regarding: i) epidemiological and healthcare data, ii) the public health policy
and interventions being considered, iii) the generation of
transmission models, and 4) the social and epidemiological
context and interpretation of model simulations. Examples
included knowledge of holiday periods, typical timing of
peak transmission of respiratory viruses, timing of restriction changes such as schools reopening and local observations of behavioural changes such as reductions in social
distancing and mask wearing. Having this valuable local
knowledge and context was in turn beneficial to in-country
collaborators, as it allowed for model scenarios to reflect
real-world public health decisions and models to estimate
epidemiological parameters with uncertainty within the
local context (e.g., the relative transmissibility of variants).
A novel, beneficial component to the collaborations
in each country has been the involvement of in-country
modellers such as those from FASSSTER and Ateneo
de Manila University in the Philippines, the National
Institute of Health (NIH) in Malaysia and the Woolcock
institute, Viet Nam (Table 1). This assisted in the clear
communication and understanding of the results and
underlying assumptions of our models to in-country
decision makers and in some cases permitted some
comparison to different models.

Challenges
The need for rapid evidence-based projections for a
newly emerging and constantly changing disease presented major challenges. With many of the AuTuMN
modellers coming from a background in tuberculosis
modelling, for which the cycle of modelling for policy
can last several months, the pressures of pandemic
modelling necessitated a major shift in approach.
Results were often required within days, and within a
few weeks projections could become irrelevant due to
changing epidemiology and policy priorities. This compounded the challenges associated with exploring and
communicating model assumptions and uncertainty
in outputs to be relevant to policy makers.2 While
model parameter choices can be explored through
standard calibration algorithms, the full uncertainty
in model projections should ideally incorporate structural choices in model construction, which were difficult to explore fully under the time constraints of the
pandemic policy cycle. Further, while our platform
supports the rapid addition of model structures to
capture processes relevant to specific policy questions, in practice there is still a considerable need
for user input. For example, structure that captures
multiple competing strains can be rapidly added
through our platform, but presents issues with calibration and output interpretation that still place a
burden on the human operator.

www.thelancet.com Vol 00 Month , 2022

Future directions
Changes in factors such as variants, disease dynamics, and vaccine coverage is leading to a shift in
COVID-19 public health response policy. Moving forward, developing a sustainable and adaptable public
health response to COVID-19 will be essential for
countries in the region to mitigate the effects of the
disease. Infectious disease modelling should be progressively integrated into domestic response capacity
in LMICs of the WPR for pandemic preparedness
and infectious diseases more broadly. With this in
mind, we are now further expanding our platform
functionality and moving towards a capacity development approach for the Philippines, Malaysia and
Viet Nam.
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